Abstract Use of apolipoprotein E genotyping to personalize the risk of a poor recovery after traumatic brain injury is complicated by the potential for genetic discrimination and the potential to reveal an increased risk for late onset Alzheimer's disease. We developed a survey to gauge interest in testing among athletes participating in National Collegiate Athletic Association programs. Eight hundred and forty seven studentathletes were surveyed to determine their interest in genetic testing, their willingness to share the results of testing with parents, coaches and physicians, their concerns about privacy and/or discrimination, and their interest in genetic counseling. Nearly three quarters of respondents expressed some level of interest in testing, with the largest number describing themselves as 'possibly interested' (54.9 %, n = 463) and a smaller number describing themselves as 'very interested' (18.9 %, n = 159). Most student-athletes said that receiving secondary information about their risk for late-onset Alzheimer's disease made them more likely to test (50.6 %, n = 426) rather than less likely to test (12.4 %, n = 104). Student-athletes were open to apolipoprotein E genotyping and willing to share test results with their parents, coaches and physicians. They did not anticipate that test results would impact their behavior or ability to play. Testing programs may be welcome but should provide clear information as to risks and benefits.
Introduction
The danger of traumatic brain injury (TBI) in athletes has been a subject of intense concern in recent years for physicians, sports leagues, schools, parents and of course the athletes themselves. As a report from the Institute of Medicine put it in 2013, Bfew issues at the intersection of medicine and sports have had as high a profile or have generated as much public interest as sports-related concussions.^ (Graham et al. 2014) . While most symptoms of sports-related TBI resolve without treatment within 2 weeks, 10-20 % of cases have a slower recovery, and individuals may experience problems that persist for months or even years (Ruff 2005) .
Clinicians have looked for prognostic indicators to identify individuals at increased risk of poor recovery, to help guide treatment and personalize advice on return to play for athletes affected by TBI. Researchers have examined genotype as well as clinical presentation and medical history. The apolipoprotein (APOE) ε4 allele, previously implicated as a risk factor for late-onset Alzheimer disease (LOAD), has been shown to increase the risk of a poor recovery and worse outcome after TBI (Teasdale et al. 1997; Eramudugolla et al. 2014; Liberman et al. 2002) . Studies indicate a relationship between APOE ε4 genotype and longer recovery time (Friedman et al. 1999) , worse performance on neurocognitive tests at 3 and 6 weeks post TBI (Liberman et al. 2002) and severity of cognitive deficit (Jordan et al. 1997; Kutner et al. 2000 ). An initial case-control study looked at outcome from TBI as assessed by the Glascow Outcome Scale. In this 1997 study, patients with a single APOE ε4 allele were more than twice as likely to have a poor outcome at 6 months (Teasdale et al. 1997) . Subsequent studies have corroborated the finding of increased risk, with odds ratios of a poor outcome for APOE ε4 carriers ranging from 3.57 to 13.93 (Diaz-Arristia and Baxter 2006) .
Unique among risk factors for poor recovery, APOE genotype can provide information in advance of injury to help athletes and their families make decisions regarding participation in sports with a high risk of TBI. Defining an acceptable level of risk is a difficult task and one that is clearly much on the minds of athletes and their parents and guardians. Football, the sport most affected by media coverage of the risks associated with sports concussion, saw participation in the Pop Warner youth football league fall almost 10 % from 2010 to 2012, according to a report by ESPN. Julian Barnes, chief medical officer for the Pop Warner league, cited concern over head injuries as the Bnumber 1 reason^for the decline (Fainaru and Fainaru-Wada 2013) . The drop off of more than 23,000 children is small relative to the absolute number of young athletes participating in high risk sports, and represents only a fraction of the families tasked with a similar dilemma. Genotype does not predetermine outcome after TBI, but could be helpful for families or individuals looking to modify generic estimates of risk, and it is reasonable to suggest that those who are searching for more information should have access to testing.
Clinical use of APOE testing is complicated by the possibility that athletes could face discrimination on the basis of their genotype. Costs and liability associated with TBI are a rising concern for schools and sports leagues. The ability to predict who is more likely to experience a worse outcome may be of interest to coaches and institutions seeking to manage their exposure to risk. Potentially, athletes could be denied the chance to participate, or to compete on an equal footing for playing time or scholarship money.
Another complication to the use of APOE genotyping in the clinical setting is the well-established link between APOE and risk of late-onset Alzheimer's disease (LOAD) (Corder et al. 1993; Strittmatter et al. 1993; Farrer et al. 1997) . Because APOE genotyping for AD has low predictive value and lacks medical utility, many organizations, including the National Society of Genetic Counselors (NSGC) and the American College of Medical Genetics (ACMG), have discouraged its use as a predictive test. A 2011 joint statement from NSGC and ACMG advises against pediatric or direct-to-consumer APOE testing, and suggests that testing for unaffected individuals should occur only in the context of extensive genetic counseling and psychological support (Goldman et al. 2011) .
Discussions on the routine use of APOE genotyping for LOAD generally posit that recommendations will change if and when the testing acquires clinical utility, but these arguments all assume clinical utility means clinical utility for LOAD (American College of Medical Genetics/American Society of Human Genetics working group on ApoE and Alzheimer disease 1995; Evans et al. 2001) . A scenario where APOE genotyping acquires clinical value that is unrelated to LOAD has not been contemplated. The pleiotropic nature of genetics complicates the strategy of using clinical utility in isolation as a measure of when to test. We are forced to weigh our costs and benefits in apples and oranges.
The ultimate arbiters of the value of APOE genotyping are not clinicians but individuals and families making their own decisions about risk and benefit, and practice should reflect an understanding of their concerns and preferences. Young athletes constitute a unique population in that for them the risk of concussion is both real and imminent, and the risk of LOAD is distant and perhaps unfamiliar. They are a group for whom APOE genotyping may be valuable, and to whom it may be offered in the near future. To date, no studies have addressed either their interest in genotyping or the extent to which that interest would be tempered by concerns about the potential negative implications of testing, including the possibility that it could interfere with their athletic career, and the possibility of receiving unsolicited information on their risk of LOAD.
Methods
This study was directed at students over age 18 participating in National Collegiate Athletic Association (NCAA) Division I, II or II athletic programs. Athletic directors at 759 schools were contacted by email, with follow-up phone calls to those who did not respond. Of the 759, 26 schools from 20 different states plus the District of Columbia agreed to participate. In each case, the athletic director, a coach or a trainer served as a contact who received reminders and delivered the survey to all student-athletes by email.
A survey instrument of 38 questions was designed to capture student-athletes' views on genetic testing for a potential increased risk of liability to poor recovery from concussion and an associated risk for increased liability to LOAD. Studentathletes were asked about their familiarity with TBI and LOAD. The questions about genetic testing were phrased hypothetically (BIf there was a test that might indicate…^), and did not presume any level of familiarity with APOE genotyping. Student-athletes were asked about their willingness to share test results with, respectively, parents and guardians, coaches and physicians. They were prompted to consider potential ramifications of sharing the information, and then asked to indicate if this was a concern for them. The genetic relationship between the increased risk for poor recovery from TBI and the increased risk of susceptibility to LOAD was explained to the studentathletes as a part of the survey. We hypothesized that the potential to learn about an increased risk for LOAD would make students less likely to test. Student-athletes were also asked about their interest in genetic counseling.
A beta version of the survey, developed on Survey Monkey, was taken by ten students meeting inclusion criteria for face validation. Feedback was incorporated into the final survey. The study received approval on September 4, 2014 from the Julia Dyckman Memorial IRB. The survey was available from September 24, 2014 to February 3, 2015. The link was forwarded to the students by our contact at each school. The survey was anonymous and voluntary. Students were informed as a part of the informed consent that no one at their school would be aware of whether or not they took the survey, or would have access to the results. All respondents were offered the chance to participate in a raffle for an Apple iPad Mini. Emails were solicited for the purpose of the raffle, but were kept separate from the results, and no identifying information was included in the analysis.
Eight hundred and forty-seven student-athletes participated in the survey, of whom 843 met inclusion criteria. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) and Survey Monkey analytics. Chi-square and one and two-tailed t-tests assessed differences in mean scores. As this was an exploratory study, a p-value of 0.05 was set for statistical significance. While appropriate, it does raise the likelihood of chance results.
Results

Characteristics of Respondents
Of the 847 student-athletes who completed the survey, 4 did not meet inclusion criteria. The remaining 843 participants ranged in age from 18 to 34, with a mean age of 19.9 years. Women (53.9 %, n = 454) slightly outnumbered men (46.1 %, n = 389). The distribution between freshmen, sophomores, juniors and seniors was balanced ( Fig. 1) with a slight overrepresentation of freshmen (28.9 %, n = 244) which likely reflects real differences in participation rates.
Just over half of our sample (54.7 %, n = 461) reported receiving a scholarship or other financial incentive for athletic participation.
Respondents were unequivocal about the importance of sport in their college experience. Most rated athletic participation as more important than any other extracurricular activity (60.4 %, n = 509) and an additional 28.1 % (n = 237) described it as the main focus of their time at college. Only 13.3 % (n = 112) expressed any doubt about using all 4 years of college eligibility, and 15.2 % (n = 128) indicated that they hoped to play at a professional level after college.
Concern about the Risk of TBI
Respondents showed familiarity with the risk of concussion as it related to their sport. We compared their categorization of their sport as high, low or moderate risk with rankings based on the 2014 NCAA Executive Summary of Self-Reported Concussion Among Student-athletes (NCAA 2014). For this purpose, any sport with a sex-specific odds ratio of concussion <2.0 relative to track and field was considered low risk (rankings of all sports included in the survey are shown in Table 1 ). Just under half of students described their own sport as low risk (46.7 %, n = 394). Their assessments showed concordance with our rankings (r = 0.72 when n = 841, p < 0.001). A substantial minority of respondents reported having had a concussion (39.9 %, n = 336), and 14.6 % of those who reported a concussion described themselves as having had a difficult recovery (5.8 % of all respondents, n = 49). Over 40 % of all respondents reported having seen a teammate experience a difficult recovery (44.7 %, n = 377).
Awareness did not necessarily translate into concern with regard to concussion risk. Asked about their level of concern, just over half said they were not concerned at all (52.6 %, n = 443), a substantial minority said they were moderately concerned (41.4 %, n = 349) and few said they were very concerned (6.0 %, n = 51). The athletes level of concern was strongly related to the risk level of their sport: 58.7 % of those in high risk sports were moderately concerned, as compared to only 27.6 % of those in low risk sports (Chi-square = 93.72, p < 0.001).
Most respondents, including those participating in high risk sports, reported that their concern about concussion risk never affected their style of play (84.5 %, n = 712).
Interest in Testing for Risk of Poor Recovery Post TBI
Student-athletes participating in the survey were generally open to the idea of genetic testing for an increased risk of a poor recovery from concussion.
Nearly three quarters of respondents expressed some level of interest in testing, with the largest number describing themselves as 'possibly interested' (54.9 %, n = 463) and a smaller number describing themselves as 'very interested' (18.9 %, n = 159).
The level of interest in testing showed a positive association with the student-athletes' perception of being at risk. Respondents who rated their sports as high risk were significantly more likely to describe themselves as 'very interested' in testing (Chi-square = 28.14, p < 0.001). Among respondents who had experienced a concussion, overall interest in testing was similar (74.4 %, n = 250) but a greater percentage of respondents described themselves as 'very interested' (25.6 %, n = 86) and those reporting a difficult recovery were significantly more likely to be 'very interested' relative to those reporting a typical or quick recovery (Chi-square = 8.98, p < 0.01). Among those who reported a difficult recovery, 42.9 % (n = 21) were 'very interested' in testing, as opposed to 22.9 % (n = 35) of those reporting a typical recovery, and 22.4 % (n = 30) of those reporting a quick recovery.
The vast majority of respondents were willing to take a genetic test for susceptibility to poor recovery if it was required by the school for participation in athletics (92.5 %, n = 780) and most remained willing to test if it was requested by the school but not mandatory (75.9 %, n = 639) or suggested by their physician (75.7 %, n = 637). Even among those who described themselves as 'not at all interested' in genetic testing, 86.9 % (n = 192) were willing to test if it was required for participation in their sport, and 57.0 % (n = 126) reported that they would test if it was requested but not required.
Perceived Consequences of Testing
Although a majority expressed an interest in testing for an increased risk of poor recovery from concussion, most respondents did not seem to anticipate much in the way of consequences from testing. Most said it would not affect their behavior (59.4 %, n = 500) or their style of play (67.4 %, n = 568). Only 15.2 % (n = 128) said they would consider giving up their sport.
Student-athletes' unconcern with potential negative consequences of testing extended to an unconcern with any potential negative implications of sharing the information. Most student-athletes reported that they would share the results with their parents (86.1 %, n = 725), coaches or team officials (75.7 %, n = 638) and physicians (86.0 %, n = 725).
The majority were not concerned about possible ramifications of disclosure. Asked about the possibility that parents would want them to give up their sport, that coaches might hesitate to play them, or that physicians would hesitate to clear them for return to play, most respondents said either that they did not believe this would influence their parents, coaches or physicians, or that it might influence them but they were not concerned. The number expressing concern about potential ramifications was lowest for parents (20.5 %, n = 173), then for coaches (31.4 %, n = 264) and highest for physicians (41.0 %, n = 345). Complete results in Fig. 2 .
Genetic Testing and Alzheimer's Disease
Most student-athletes showed some familiarity with Alzheimer's disease (Fig. 3) .
Respondents were informed that the test for higher risk of poor recovery from concussion might reveal an increased risk for LOAD. Most respondents did suggest some level of concern about receiving this information. Most respondents were either moderately concerned (49.3 %, n = 416) or very concerned (16.8 %, n = 142) about other people knowing if they had an increased risk for LOAD. Asked which was more true, respondents were split between those concerned about other people knowing (32.5 %, n = 274) and concern about having this information themselves (24.1 %, n = 203).
Despite these concerns, 85.9 % of student-athletes showed an interest in receiving information about their risk for LOAD. A majority described themselves as 'moderately interested( 51.4 %, n = 433) and a smaller but still substantial number described themselves as 'very interested^(34.5 %, n = 291).
We had hypothesized that the possibility of receiving information about an increased risk for LOAD might make students more hesitant to test. In fact, a majority of respondents said the chance to learn more about their risk for LOAD would make them more likely to take the test (50.6 %, n = 426) and another 37.1 % (n = 312) said it made no difference one way or another (Fig. 4) . Only 12.4 % (n = 104) reported that it would make them less likely to take the test.
Interest in Genetic Counseling
Students athletes were asked about their interest in genetic counseling and just over half of all respondents said that having the option to meet with a genetic counselor would make them feel more comfortable about having genetic testing (51.5 %, n = 434). In the survey, a genetic counselors were defined as Btrained professionals who meet with individuals to discuss the potential ramifications of genetic testing and to help interpret the results of genetic testing. More students preferred to meet with a genetic counselor to explain the results of testing (62.5 %, n = 527) than to meet with a genetic counselor before deciding whether or not to have genetic testing (35.8 %, n = 302).
Discussion
Student-athletes in our survey showed a striking openness to genetic testing for increased liability to poor recovery from TBI as well as LOAD, and to sharing the test results with coaches, athletic directors, parents and doctors. The majority expressed some level of personal interest in testing for liability to poor recovery, with 18.9 % describing themselves as Bvery interested.^Even more were willing to take a test if it was We anticipated that student-athletes might not have carefully considered all the potential ramifications of testing. The survey attempted to walk them through some concerns that they might have, including ways in which a test result might impact their ability to play. Most students, when prompted, anticipated that their parents might ask them to give up their sport, that their coaches or athletic staff might hesitate to play them, or that their physician might hesitate to clear them for return to play. In each case a majority of students said either that they did not think that would happen or that it was not a concern for them. Of the three, they were most worried about physicians, and 41.0 % of respondents said they were concerned that their physician would impede their return to play. Still, 86.0 % of respondents said they would share the test results with their physician.
Clearly, their willingness to share test results is not a reflection of a cavalier attitude toward participation in sport. Respondents left us in no doubt about the importance of their athletic careers. Almost 90 % described their sport as either Bmore important than any other extra-curricular activity^or Bthe main focus of their time at college.^Only 15.2 % said they would consider giving up their sport if their test result showed a higher risk of difficult recovery from concussion, although nearly a third said it would affect their style of play.
Given their desire and intent to play, the students' willingness to test and to share test results seems to indicate a lack of concern with consequences, which might simply reflect the thinking of a respondent pool whose average age is 19.9 years. But there is substantial evidence that their openness to testing reflects their level of concern and an accurate understanding of their own risk. Students' level of interest in testing showed a significant increase with participation in higher risk sports and personal experience of a concussion, either their own or seeing a teammate with a difficult recovery.
Testing for an increased risk for LOAD is controversial, and we anticipated that it might be a barrier to clinical use of APOE genotyping. Contrary to our expectations, students expressed even more interest in testing for an increased risk of LOAD than for an increased risk of poor recovery from TBI. Again, we walked students through some potential concerns via the questions. Over 65 % were either moderately concerned or very concerned about other people knowing if that had an increased risk of AD, and 24.1 % said they themselves would not like to know. Still, only 12.4 % reported the possibility of learning about an increased risk of LOAD made them less likely to test, and 50.6 % reported that it made them more likely to test. Most of our respondents were familiar with AD, and knowing someone with the disease made students more likely to be interested in testing.
Both applications of APOE genotyping, the association with poor recovery from TBI and the association with an increased risk for LOAD, are freighted with the potential for genetic discrimination. Student-athletes' openness to getting and sharing their APOE genotype may suggest that they do not adequately appreciate the possible implications of testing, but their responses to questions about consequences show an awareness of potential risks. Interest in testing rose with exposure to poor recovery in a teammate, personal experience of poor recovery, personal exposure to LOAD, or participation in a high risk sport, indicating a rational process of assessing risks and benefits. Most respondents express some level of concern, but it is rarely enough to rule out testing. Typical to the pattern, nearly two thirds of respondents reported that they would be more likely to test if they knew that the results would not be shared with the school, but 92.5 % would agree to test if the school required it for participation. It is possible that their attitude reflects a mere adolescent disregard of consequences, but it is also possible that their answers are illustrative of a Fig. 4 Potential secondary findings on risk of late-onset Alzheimer's disease risk: impact on student-athletes' interest in APOE genotyping generation less concerned about privacy and more comfortable with genetic testing.
Whether or not schools would consider this use of APOE genotyping is a question that has not been asked. Not everyone with an APOE ε4 genotype will have a poor recovery from TBI and not everyone with a poor recovery will have an APOE ε4 genotype. Given the limits to predictive value, schools may not feel it is useful to identify athletes or recruits with an APOE ε4 genotype. On the other hand, a lawsuit filed against the NCAA by former players began by asking for 70 million dollars to test current and former athletes for TBI, an amount the judge described as Bpotentially insufficient( The New York Times 2014). A settlement currently under review by the court in the class action suit would require the NCAA to adopt tougher concussion management guidelines (USAToday 2015). For high risk sports like football, TBI may be an existential issue, and the opportunity to limit liability could be compelling.
Genetic testing in collegiate athletics has precedent, as currently all NCAA athletes are screened for sickle cell trait, a program introduced in 2010 after the death during training of an Rice University athlete who was a sickle cell carrier (Tarini et al. 2012 ). The sickle cell testing program has been criticized for exposing athletes to potential genetic discrimination (Thompson 2013) . Ferrari et al. have argued that the program, Bembedded in the hierarchical structure of the collegiate environment,^is in effect mandatory despite an opt out provision, and will lead to likely violations of privacy (Farrari et al. 2015) . Our results support the assumption that studentathletes are likely to agree to any test required by the school as a condition of participation.
One of the criticisms lodged against the sickle cell screening program by the American Society of Hematology and others is that the risks of sickle cell carrier status are not well defined and the association with sudden death remains unproven (American Society of Hematology 2012; Sickle Cell Disease Association of America 2015; Secretary's Advisory Committee on Heritable Disorders in Newborns and Children 2010). Still, the risks associated with sickle cell trait are more straightforward and easily managed than the risks associated with APOE ε4 genotype, which affects a far larger swath of the population. Guidelines developed by the NCAA for athletes with sickle cell trait include precautionary measures that ensure better hydration and prevent overheating (NCAA 2015) . While testing for APOE genotype could mitigate legal exposure for schools or leagues by providing for a more informed consent before participation, there is no way to avoid the risk of head injury short of not allowing athletes to play.
Whether or not schools may legally request genetic testing of athletes or recruits is a matter of debate. Under Title II of the Genetic Non-Discrimination Act of 2008 (GINA), employers cannot request, require or purchase genetic information on employees or applicants or use that information to make decisions about hiring, benefits, training or job assignments [H.R. 493; the Genetic Non-Discrimination Act of 2008]. The legal status of NCAA schools with regard to studentathletes is currently being litigated (US News and World report 2015) . As the use of genetic testing becomes more common, the ethical and legal repercussions and implications for athletes will likely come under increased scrutiny (Evans 2009 ).
It's hard to predict whether or not NCAA schools would request or require APOE genotyping if permitted under law. We make the argument that testing would have great appeal to programs in an era where there is so much concern about risk and liability secondary to TBI. Given their age and the premium that they put on athletic participation, student-athletes are as a group vulnerable to testing programs that may be coercive. This does not mean that testing is inappropriate, but it does mean that testing, if initiated, should include safeguards to prevent coercion and genetic discrimination. Since genetics is not destiny and all students are at risk of TBI, genetic testing should never be used to distract from or displace efforts to make sports safer for all participants. Subsequent studies might query athletic directors and/or coaches about their interest in APOE genotyping and their familiarity with the genetics of TBI.
Potentially, an emphasis on genotyping could displace or distract from efforts to make the sport safer for all students.
Our study had a number of limitations. Of 759 schools we approached, 26 agreed to provide student-athletes with our survey. A number of schools declined to say how many students participated on their NCAA teams, and therefore we were unable to reliably assess our response rate. Our sample of 843 student-athletes may reflect a bias both in which students and which schools opted to participate. We did not assess student-athletes' knowledge of genetics, although familiarity with the science might have influenced their responses. We did not assess their understanding of the survey questions or the explanations we provided. Most importantly, all answers in this study were based on hypothetical scenarios and may not accurately reflect student-athletes' decision-making when confronted with choices in real situations and in real time.
APOE genotyping raises a number of complex issues. It is clear from our results that most students would be willing to participate, and in fact many of them suggest that they would be anxious to participate. It is less clear whether or not they understand all the potential implications of testing APOE ε4 positive. Guidelines for the use of APOE genotyping should therefore include an emphasis on counseling, and transparency with regard to how results would be used by team doctors, coaches or athletic directors.
Just over half of the student-athletes in our study reported that the option to meet with a genetic counselor would make them more comfortable with genetic testing. Respondents showed more interest in meeting with a counselor to explain results (62.5 %) than to decide whether or not to test (35.8 %) . The impact of counseling may therefore be maximized as a part of return of results, although given the range of issues there are topics that should be raised before testing, including the right to decline testing. Future studies might look at the relative effectiveness of pre-test counseling versus educational materials in this setting.
APOE genotyping raises some difficult questions about the value and the cost of predictive information. Predictive testing has baked-in uncertainty, and the value of it may be lost without careful explanation or a sophisticated understanding of risk. To the extent that predictive information is useful, it may be hard to control how it is used. APOE, like most genes, is pleiotropic in effect, and appropriate use and counseling must take into account all the potential implications, not only the problem at hand. None of these issues is unique to APOE, and all of them will arise repeatedly as clinical genetic testing becomes more commonplace. As with APOE, one potential approach to these complexities is to shy away from testing. It might be easier to assume that young athletes are better off not getting information that might be used to discriminate against them. Most athletes in our study, however, did not take this more conservative approach. Despite acknowledging a number of concerns, our respondents showed substantial interest in and little resistance to the idea of genetic testing for the purpose of risk assessment.
